Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
678 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-03
Compose a Response to This Article
Other responses
No responses have been published for this article.